Eledon Pharmaceuticals Inc (ELDN)
SG&A Expense Growth
16.44%
Quarterly · Period ending:
ELDN SG&A Expense Growth
Latest reported16.44%period ending
Latest reported16.44%period ending
ELDN Quarterly SG&A Growth (QoQ) (0.00% → 16.44%)
Latest values, visible window
High-resolution chart · PNG
ELDN sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 16.4408% | |
| -0.2254% | |
| -2.6335% | |
| -7.9874% | |
| 0.5414% | |
| -34.5006% | |
| 69.6241% | |
| -9.2357% | |
| 27.0888% | |
| 5.7475% | |
| 0.1224% | |
| 3.6156% | |
| 5.2052% | |
| 7.4194% | |
| -11.316% | |
| -11.1299% | |
| 9.8015% | |
| 0.6556% | |
| 12.4649% | |
| -23.6256% | |
| 11.247% | |
| 0.9031% | |
| -10.9622% | |
| 194.011% | |
| -26.6474% | |
| 78.9038% | |
| -31.467% | |
| -21.2612% | |
| -4.9841% | |
| 2.6674% | |
| -0.5952% | |
| -0.6452% | |
| 9.5406% | |
| 5.335% | |
| -34.1503% | |
| -60.0848% | |
| 576.9316% | |
| -66.7401% | |
| 382.9787% | |
| 65.8824% | |
| -90.4198% | |
| 6.2893% | |
| -2.2541% | |
| 9.2421% | |
| 14.0825% | |
| 11.5588% | |
| -31.731% | |
| 141.0583% | |
| 11.7515% | |
| 11.3333% | |
| 81.5431% | |
| 0% |